Cochrane Abstracts
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bromocriptine/levodopa Combined Versus Levodopa Alone for Early Parkinson's Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439066/all/Bromocriptine_levodopa_combined_versus_levodopa_alone_for_early_Parkinson&apos.
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/all/Bromocriptine_levodopa_combined_versus_levodopa_alone_for_early_Parkinson&apos. Accessed February 11, 2026.
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/all/Bromocriptine_levodopa_combined_versus_levodopa_alone_for_early_Parkinson&apos
Bromocriptine/levodopa Combined Versus Levodopa Alone for Early Parkinson's Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/all/Bromocriptine_levodopa_combined_versus_levodopa_alone_for_early_Parkinson&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
ID - 439066
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/all/Bromocriptine_levodopa_combined_versus_levodopa_alone_for_early_Parkinson&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
